 |
市场调查报告书
商品编码
1673058
肾上腺素市场按产品类型、应用、分销管道和地区划分Epinephrine Market, By Product Type, By Application, By Distribution Channel, By Geography |
||||||
价格
简介目录
2025 年全球肾上腺素市场规模估计为 32.5 亿美元，预计到 2032 年将达到 71.1 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 11.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 32.5亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025 年至 2032 年复合年增长率 | 11.80％ | 2032 年金额预测 | 71.1亿美元 |
数字。 2025 年肾上腺素市场占有率（按地区）
肾上腺素是一种荷尔蒙和药物，用于治疗许多疾病，包括过敏反应、心臟麻痹和表皮出血。作为一种注射药物，它用于治疗血管性水肿和过敏反应等过敏反应。它也可以用于预防因运动引起支气管收缩的人的气喘发作。气喘等疾病的增加可能会增加对肾上腺素自动注射器的需求。肾上腺素成为过敏反应的标准治疗方法，加上自动注射器的技术进步，可能会推动市场成长。
市场动态
全球肾上腺素市场的成长受到多种因素的推动，例如过敏反应和过敏反应发病率的增加、自动注射器技术的进步提高了给药的便利性、紧急医疗环境的需求不断增加以及肾上腺素自动注射器作为过敏反应的一线治疗手段的应用日益广泛。然而，自动注射器高成本、注射肾上腺素短缺导致价格上涨以及对替代治疗方案的偏好等因素可能会阻碍市场成长。生物相似药肾上腺素的出现及其在新兴市场的渗透可以在预测期内为市场参与企业提供成长机会。
研究的主要特点
- 本报告对全球肾上腺素市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。
- 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球肾上腺素市场的主要企业。
- 本报告的见解有望使负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球肾上腺素市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 透过分析全球肾上腺素市场所使用的各种策略矩阵，相关人员可以更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- 一致的机会图 (COM)
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 市场趋势
- 监管情景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
4. 全球肾上腺素市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 2020-2032 年全球肾上腺素市场（按产品类型划分）（十亿美元）
- 介绍
- 自动注射器
- 预填充式注射器
- 安瓿瓶与管瓶
6. 2020 年至 2032 年全球肾上腺素市场（按应用划分）（十亿美元）
- 介绍
- 过敏反应
- 心臟麻痹
- 表皮出血
- 呼吸系统疾病
- 其他的
7. 2020-2032 年全球肾上腺素市场按通路划分（十亿美元）
- 介绍
- 医院药房
- 零售药局
- 网路药局
8. 2020 年至 2032 年全球肾上腺素市场（按地区划分）（十亿美元）
- 介绍
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第九章 竞争格局
- 公司简介
- Pfizer
- Harvest Pharmaceuticals
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi SA
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Emerade
- Antares Pharma Inc.
第 10 章分析师建议
- 兴衰
- 一致的机会地图
第 11 章 参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI2401
Global Epinephrine Market is estimated to be valued at USD 3.25 Bn in 2025 and is expected to reach USD 7.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.25 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.80% | 2032 Value Projection: | USD 7.11 Bn |
Figure. Epinephrine Market Share (%), By Region 2025
Epinephrine, also known as adrenaline, is a hormone and medication that is used to treat a number of medical conditions such as anaphylaxis, cardiac arrest, and superficial bleeding. As an injection, it is used to treat allergic reactions like angioedema or anaphylaxis. It may also be used by people with exercise-induced bronchoconstriction to prevent asthma attacks. Rising diseases like asthma can boost demand for epinephrine auto-injectors. Emergence of epinephrine as the standard treatment for anaphylaxis along with technological advancements in autoinjectors can drive the market growth.
Market Dynamics:
Global epinephrine market growth is driven by factors such as rising incidences of anaphylaxis and allergic reactions, technological advancements in auto-injectors improving ease of administration, increasing demand from emergency medical settings, and growing adoption of epinephrine auto-injectors as the first line treatment for anaphylaxis. However, factors such as high costs associated with auto-injectors, shortage of injectable epinephrine exacerbating prices, and preference for alternative therapeutic options can hamper the market growth. Emergence of biosimilar epinephrine and expansion into developing regions can offer growth opportunities for market players during the forecast period.
Key Features of the Study:
- This report provides in-depth analysis of the global epinephrine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global epinephrine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, LLC, Kaleo, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global epinephrine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epinephrine market.
Detailed Segmentation-
- By Product Type
- Auto-injector
- Prefilled Syringes
- Ampoules and Vials
- By Application
- Anaphylaxis
- Cardiac Arrest
- Superficial Bleeding
- Respiratory Disorders
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Pfizer
- Harvest Pharmaceuticals
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi S.A.
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Antares Pharma Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Epinephrine Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Epinephrine Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Auto-injector
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prefilled Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ampoules and Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Epinephrine Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Anaphylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Arrest
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Superficial Bleeding
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Respiratory Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Epinephrine Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Epinephrine Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Pfizer
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Harvest Pharmaceuticals
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi S.A.
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Emerade
- Antares Pharma Inc.
- Pfizer
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
